RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL
NCT04620655
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
24
Enrollment
OTHER
Sponsor class
Conditions
T Acute Lymphoblastic Leukemia
T-lymphoblastic Lymphoma
Interventions
DRUG:
RD13-01 cell infusion
Sponsor
Min Xiang